The Quantum Group Announces Filing of Multiple Patents
17 Enero 2008 - 7:00AM
PR Newswire (US)
WELLINGTON, Fla., Jan. 17 /PRNewswire-FirstCall/ -- The Quantum
Group, Inc. (AMEX:QGPAMEX:QGP.WS.AAMEX:QGP.WS.B)
(http://www.quantummd.com/) today announced that it has recently
filed five provisional business process patents with the United
States Patent and Trademark Office for technologies that reflect
and underscore the comprehensive approach of the Company to the
healthcare industry. The patents filed address the needs of both
patients and healthcare providers, while offering an intelligent,
knowledge-based approach to patient care. Pete Martinez, Senior
Vice President and Chief Technology & Innovations Officer of
The Quantum Group stated, "With the filing of these patents,
Quantum continues to develop the tools that will propel our
business model to improve the science of healthcare." Martinez
continued, "Upon completion, these tools will have cross-functional
benefits that are intended to empower patients to improve their
healthcare experience and wellness, and will offer providers the
opportunity to achieve increased efficiency, effectiveness and
quality of service." Noel J. Guillama, President and CEO of The
Quantum Group explains, "The healthcare industry is highly
fragmented -- a trait that our Company has identified as both its
greatest challenge and as our most significant opportunity to bring
about industry wide solutions. Our patent-pending technologies
transcend the fragmented channels of healthcare and offer solutions
that present benefits for patients, payers and for our customers,
the healthcare providers themselves." Guillama, inventor of
multiple technologies at the foundation of Company initiatives, has
transferred 50 percent ownership of these inventions to the Company
to benefit the continued progress of Quantum technology development
and deployment. Martinez concluded, "We as a Company are just
beginning to scratch the surface of our long-range plans. I expect
further developments in the coming months regarding the progress of
these provisional patents and of the additional innovations
protected by patent applications that will be part of our continued
efforts to bring healthcare from the industrial era to the
information age." Martinez joined The Quantum Group in July of 2007
after retiring from a 32 year career with IBM, most recently
serving IBM as Vice President and Senior Location Executive for
South Florida. A recognized and proven innovative business leader,
Martinez has been a catalyst for industry transformations as he has
applied his multi-disciplinary experience and expertise to
industries ranging from finance, manufacturing, biotech, government
and academia. In recent years, Martinez became fascinated with the
healthcare industry as he recognized it was one of the few
remaining industries that had not yet leveraged the new business
models, processes and technologies of the 21st Century. He sees The
Quantum Group as the ideal company to impart a significant impact
across the industry. About the Company The Quantum Group, Inc. is a
Florida-based organization. The Company builds and manages
healthcare systems and offers consulting and outsourcing services
that will be leveraged by leading-edge technology to the nation's
largest and fastest growing industry -- healthcare. The Company is
engaged in the development and execution of a series of innovative
technology initiatives designed to make Quantum one of the state's
leading providers of business solutions for the healthcare
industry. Through its growing number of nearly 1,600 contracted
physicians and managed care relationships in the state of Florida,
the Company believes it is positioned to bring increased
efficiencies to the Florida healthcare industry. Certain statements
contained in this news release, which are not based on historical
facts, are forward-looking statements as the term is defined in the
Private Securities Litigation Reform Act of 1995, and are subject
to substantial uncertainties and risks in part detailed in the
respective company's Securities and Exchange Commission 10-KSB,
10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause
actual results to materially differ from projections.
Forward-looking statements can be identified by the use of words
such as "expects," "plans," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates" and other words of
similar meaning. These statements are subject to risks and
uncertainties that cannot be predicted or quantified and,
consequently, actual results may differ materially from those
expressed or implied by these forward-looking statements. Such risk
factors include, without limitation, the ability of the Company to
properly execute its business model, to raise substantial and
immediate additional capital to implement its business model, to
attract and retain executive, management and operational personnel,
to negotiate favorable current debt and future capital raises, to
negotiate favorable agreements with a diversified provider base and
to continue to supply the services needed by its HMO clients as
well physician clients. The Company does not undertake any
obligation to publicly update any forward-looking statements. There
can be no assurance that the provisional patents discussed in this
press release will be granted by the US Patent and Trademark
Office, or, if they are granted, they will not be challenged by
third parties, or if not that we will be able to effectively use or
commercialize such patents and/or we may not have the resources to
deploy such technology. As a result, investors should not place
undue reliance on these forward-looking statements. FOR MORE
INFORMATION, PLEASE CONTACT: Elite Financial Communications Group,
LLC Daniel Conway, Chief Strategist 407.585.1080 or via email at Or
Danielle Amodio Vice President, Corporate Communications The
Quantum Group, Inc. 561.798.9800 DATASOURCE: The Quantum Group,
Inc. CONTACT: Daniel Conway, Chief Strategist of Elite Financial
Communications Group, LLC, +1-407-585-1080, ; or Danielle Amodio,
Vice President, Corporate Communications of The Quantum Group,
Inc., +1-561-798-9800 Web site: http://www.quantummd.com/
Copyright